Liberating the data from clinical trials: Liberated trial data have enduring potential to benefit patients, prevent harm, and correct misleading research

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Henry, David ^a,b   Fitzpatrick, Tiffany ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c Support Unit   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE;

CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; FUNDING; HARM REDUCTION; HUMAN; INVESTMENT; MAJOR DEPRESSION; MEDICAL RESEARCH; PRIORITY JOURNAL; REPRODUCIBILITY; RESPONSIBILITY; TREATMENT PLANNING; INFORMATION DISSEMINATION; MEASUREMENT ACCURACY;

CLINICAL TRIALS AS TOPIC; DATA ACCURACY; HUMANS; INFORMATION DISSEMINATION;

EID: 84945921057     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h4601     Document Type: Editorial

References (26)

1. Le Noury J, Nardo J, Healy D, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015:351:h4320.
2. Keller M, Ryan N, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72.
3. Doshi P. No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility. BMJ 2015:351:h4629.
4. Doshi P, Dickersin K, Healy D, Vedula S, Jefferson T. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ 2013:346; f2865.
5. Ebrahim S, Sohani Z, Montoya L, et al. Reanalyses of randomized clinical trial data. JAMA 2014:312:1024-32.
6. +AI IT rials. About Al ITrials. www.alltrials.net/find-out-more/about-alltrials/.
7. Chalmers I, Glasziou P, Godlee F. All trials must be registered and the results published. BMJ 2013;346:f105.
8. Goldacre B. Scientists are hoarding data and it's ruining medical research, www.buzzfeed. com/bengoldacre/deworming-trials.
9. Davey C, Aiken A, Hayes R, Hargreaves J. Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a statistical replication of a cluster quasi-randomized stepped-wedge trial. Int J Epidemiol 2015, July 22 (epub ahead of print).
10. Miguel E, Kremer M. Worms: identifying impacts on education and health in the presence of treatment externalities. Econometrica 2004:72:159-217.
11. Government of Canada, Policies and Guidelines. Open access-research data. www.science, gc.ca/defau It.asp?lang=en&n=2BBD98C5-1.
12. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993:329:977-86.
13. Epidemiology of Diabetes Interventions and Complications (EDIC). EDIC publications. https://edic.bsc.gwu.edu/web/edic/publications.
14. Open Knowledge. What is open? https://okfn.org/opendata/.
15. National Institutes of Health. NIH data sharing repositories. www.nlm.nih.gov/NIHbmic/nih-data-sharing-repositories.html.
16. Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. National Academies Press, 2015.
17. Varnai P, Rentel M, Simmonds P, et al. Assessing the research potential of access to clinical trial data. Technopolis Group, 2015.
18. Council of Canadian Academies. Accessing health and health-related data in Canada, the expert panel on timely access to health and social data for health research and health system innovation. Council of Canadian Academies, 2015.
19. Loder E, Groves T. The BMJ requires data sharing on request for all trials. BMJ 2015;350:h2373.
20. Tu J, Donovan L, Lee D, et al Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA 2009:302:2330-7.
21. Steventon A, Bardsley M, Billings J, et al. Effect of telehealth on use of secondary care and mortality: findings from the whole system demonstrator cluster randomised trial. BMJ 2012;344:e3874.
22. Roberts M, Stokes J, King M, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001;51:257-65.
23. Packard C, Ford I, Murray H, McCowan C. Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year followup of the West of Scotland Coronary Prevention Study [abstract]. American Heart Association's Scientific Sessions. Chicago, 2014.
24. Barry SE, Din nett E, Kean S, Gaw A, Ford I. Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention Study. PLoS One 2013;8:e75379.
25. Miller A, Wall C, Baine C, et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014;348:g366.
26. Ontario SPOR Support Unit. Work we support-data platforms & services. 2015. http://ossu.ca/work-we-support/data-platforms-services/.